EFFECTS OF PHENTOLAMINE, DIHYDROERGOCRISTINE AND ISOXSUPRINE ON THE BLOOD PRESSURE AND HEART RATE IN HORMOTENSIVE, HYPOTENSIVE AND HYPERTENSIVE RATS.MORPURGO C; FAINI D; FALCONE A et al.1975; ARCH. (NAUNYN-SCHMIEDEBERG'S) PHARMACOL.; GERM.; DA. 1975; VOL. 290; NO 4; PP. 335-346; BIBL. 16 REF.Article

Future strategies and adjuvant treatment of gastric cancerFALCONE, A.Annals of oncology. 2003, Vol 14, pp ii45-ii47, issn 0923-7534, SUP2Conference Paper

ACTH fragments reverse experimental haemorrhagic shock in ratsCOPPI, G; FALCONE, A.Drugs under experimental and clinical research. 1992, Vol 18, Num 5, pp 173-177, issn 0378-6501Article

The phytotropin releasing hormone analogue, RGH 2202, reverses experimental haemorrhagic shock in ratsCOPPI, G; FALCONE, A.European journal of pharmacology. 1990, Vol 182, Num 1, pp 185-188, issn 0014-2999, 4 p.Article

ANATOMIA CHIRURGICA DEL SISTEMA PORTALE NEL RATTO = ANATOMIE CHIRURGICALE DU SYSTEME PORTE CHEZ LE RATINNOCENTI P; COTELLESE R; FALCONE A et al.1978; BOLL. SOC. ITAL. BIOL. SPER.; ITA; DA. 1978 PUBL. 1979; VOL. 54; NO 23; PP. 2421-2425; BIBL. 2 REF.Article

An acute neurologic syndrome temporally associated with postexposure treatment of rabies. CommentaryMORTIERE, M. D; FALCONE, A. L; PLOTKIN, S.A et al.FALCONE, A. L; Pediatrics (Evanston). 1997, Vol 100, Num 4, pp 720-721, issn 0031-4005Article

DISCOVERY OF HIGH-ENERGY AND VERY HIGH ENERGY γ-RAY EMISSION FROM THE BLAZAR RBS 0413ALIU, E; ARCHAMBAULT, S; BUGAEV, V et al.The Astrophysical journal. 2012, Vol 750, Num 2, issn 0004-637X, 94.1-94.6, 1Article

Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working PartyD'ARENA, G; VALENTINI, C. G; SEMENZATO, G et al.Annals of oncology. 2012, Vol 23, Num 6, pp 1499-1502, issn 0923-7534, 4 p.Article

VERITAS OBSERVATIONS OF THE TeV BINARY LS I +61° 303 DURING 2008-2010ACCIARI, V. A; ALIU, E; CANNON, A et al.The Astrophysical journal. 2011, Vol 738, Num 1, issn 0004-637X, 3.1-3.8, 1Article

Bortezomib, doxorubicin and dexamethasone in advanced multiple myelomaPALUMBO, A; GAY, F; AVONTO, I et al.Annals of oncology. 2008, Vol 19, Num 6, pp 1160-1165, issn 0923-7534, 6 p.Article

Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapyGRAZIANO, F; RUZZO, A; MASI, G et al.British journal of cancer. 2008, Vol 99, Num 5, pp 716-721, issn 0007-0920, 6 p.Article

Phase II study of sequential chemotherapy with docetaxel-estramustine followed by mitoxantrone-prednisone in patients with advanced hormone-refractory prostate cancerGALLI, L; FONTANA, A; FALCONE, A et al.British journal of cancer. 2007, Vol 97, Num 12, pp 1613-1617, issn 0007-0920, 5 p.Article

Discovery of an extreme MeV blazar with the Swift burst alert telescopeSAMBRUNA, R. M; MARKWARDT, C. B; ALLER, H. D et al.The Astrophysical journal. 2006, Vol 646, Num 1, pp 23-35, issn 0004-637X, 13 p., 1Article

Prolonged gemcitabine infusion in advanced non-small-cell lung cancer with stable disease after gemcitabine 30-min infusionTIBALDI, C; BERNARDINI, I; CHELLA, A et al.Lung cancer. 2006, Vol 51, Num 2, pp 217-223, issn 0169-5002, 7 p.Article

Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancerSOBRERO, A; FRASSINETI, G; FALCONE, A et al.British journal of cancer. 2005, Vol 92, Num 1, pp 24-29, issn 0007-0920, 6 p.Article

Cyclophosphamide-methotrexate 'metronomic' chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluationBOCCI, G; TUCCORI, M; EMMENEGGER, U et al.Annals of oncology. 2005, Vol 16, Num 8, pp 1243-1252, issn 0923-7534, 10 p.Article

Inter-observer agreement of the physician's global assessment of disease activity in children with juvenile idiopathic arthritisFALCONE, A; CASSONE, R; ROSSI, F et al.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 1, pp 113-116, issn 0392-856X, 4 p.Article

Suramin in patients with metastatic colorectal cancer pretreated with fluoropyrimidine-based chemotherapy : a phase II studyFALCONE, A; PFANNER, E; CIANCI, C et al.Cancer. 1995, Vol 75, Num 2, pp 440-443, issn 0008-543XArticle

sVCAM-1 levels after segmental antigen challenge correlate with eosinophil influx, IL-4 and IL-5 production, and the late phase responseZANGRILLI, J. G; SHAVER, J. R; CIRELLI, R. A et al.American journal of respiratory and critical care medicine. 1995, Vol 151, Num 5, pp 1346-1353, issn 1073-449XConference Paper

The effect of scrubbing and irrigation with normal saline, povidone iodine, and cefazolin on wound bacterial counts in a guinea pig modelHOWELL, J. M; STAIR, T. O; HOWELL, A. W et al.The American journal of emergency medicine. 1993, Vol 11, Num 2, pp 134-138, issn 0735-6757Conference Paper

FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancerLOUPAKIS, F; CREMOLINI, C; ANTONIOTTI, C et al.European journal of cancer (1990). 2014, Vol 50, Num 1, pp 57-63, issn 0959-8049, 7 p.Article

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancerBAJETTAL, E; FLORIANI, I; NITTI, D et al.Annals of oncology. 2014, Vol 25, Num 7, pp 1373-1378, issn 0923-7534, 6 p.Article

FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO)FORNARO, L; LONARDI, S; ZANIBONI, A et al.Annals of oncology. 2013, Vol 24, Num 8, pp 2062-2067, issn 0923-7534, 6 p.Article

VERITAS OBSERVATIONS OF DAY-SCALE FLARING OF M 87 IN 2010 APRILALIU, E; ARLEN, T; CANNON, A et al.The Astrophysical journal. 2012, Vol 746, Num 2, issn 0004-637X, 141.1-141.7, 1Article

Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patientsVINCENZI, B; GALLUZZO, S; RUZZO, A et al.Annals of oncology. 2011, Vol 22, Num 5, pp 1141-1146, issn 0923-7534, 6 p.Article